Lufax Holding Ltd: Amended and Restated Nomination and Remuneration Board Committee Charter

Bulletin Express
2025/10/24

Lufax Holding Ltd announced an amended and restated charter for its Nomination and Remuneration Board Committee, effective upon the company’s listing on the Hong Kong Stock Exchange. The charter sets out the Committee’s responsibilities concerning the identification of qualified Board and executive officer candidates, Board composition procedures, overall corporate governance practices, and remuneration policies.

According to the document, the Committee must consist of at least three directors, with a majority being independent non-executive directors. The chairperson must also be an independent non-executive director. The Committee will convene at least twice annually and is empowered to make recommendations on selecting and appointing directors, reviewing Board size and structure, assessing the independence of non-executive directors, and overseeing succession planning for key leadership roles.

The charter outlines corporate governance duties, including reviewing the company’s governance policies, monitoring director and senior management training, and ensuring compliance with relevant legal and regulatory requirements. It also details the Committee’s role in executive compensation, emphasizing performance evaluations, formal procedures for setting remuneration, and the need for transparent disclosures. Compensation policies for directors and senior management, as well as reviews of incentive and equity-based plans, are integral parts of the Committee’s remit.

The Committee is authorized to investigate or study any matters within its responsibilities and may retain independent advisers as needed. For compensation-related matters, the Committee oversees the appointment and supervision of any external advisers, taking into account their independence and potential conflicts of interest. The committee will regularly evaluate its performance under the charter to align with evolving governance standards and market regulatory requirements.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10